- Meeting abstract
- Open Access
P03-015 - Dapson treats chronic Pupura Schoenlein (PSH)
Pediatric Rheumatology volume 11, Article number: A213 (2013)
PSH is common and, with few exceptions, resolves spontaneously. In complicated cases treatment can be difficult.
Here we present an 11 year old Iranian girl, of healthy parents suffered from chronic PSH with chronic exanthema, severe ulcerative dermatitis and arthralgia. Clinical observation: no fever, no arthritis, no signs of polyserositis or hepatosplenomegaly; Laboratory: normal values (full blood count, CRP, complement (C3, C4), no autoantibodies (ANA, ANCA, anti-ds-DNA), no cryoglobulins, zinc, IgG, IgM). Abnormal findings: highly elevated IgA in serum (maximum 2030 mg/dl), elevation of ESR and MRP8/ 14. Skin biopsy: leukocytoclastic infiltrates in subcutaneous fatty tissue. Immunohistochemistry: IgA deposits in tip of papillae and upper corium. No mutation in Marenostrin was found. Multimodal therapeutic approaches (Cortisone, Methotrexate, Azathioprine, Colchicine, i.v. Immunoglobulins) remained without success for 8 years. With the administration of Dapsone symptoms resolved within days and remain under control for > 8 months now. Met-Hb level is tolerable.
Anti-inflammatory potency of dapsone is illustrated. Therapeutic efficacy of Dapsone has been reported in chronic PSH[1, 2], but the mechanism remains to be fully elucidated. Hypothesis: Endothelial cells and hyperreactive B-cells (as illustrated by IgA elevation) secrete IL-8. IL-8 is elevated in patients with PSH . IL-8 stimulates perivascular invasion by neutrophils. Dapsone can inhibit secretion of IL-8 , thereby impairing neutrophil function [5–7].
In conclusion Dapsone might be benefical for complicated cases of PSH. The mechanism of its anti-inflammatory potency remains to be elucidated.
Evans : Arch Child Dis. 2004
Papandreou T: Eur J Dermatology. 2010
Yang : Ann Rheuma Dis. 2004
Schmidt : Clin Exp Immunology. 2011
Thuong-Nguyen V: J Invest Dermatol. 1993
Debol : J Leuko Biol. 1997
Suda : Br J Dermatology. 2005
Rights and permissions
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
About this article
Cite this article
Dueckers, G., Frosch, M., Assaf, C. et al. P03-015 - Dapson treats chronic Pupura Schoenlein (PSH). Pediatr Rheumatol 11 (Suppl 1), A213 (2013). https://doi.org/10.1186/1546-0096-11-S1-A213
- Fatty Tissue